current user: public
If you have questions about the server, please let us know.

Query: IDP05561 peptidoglycan binding protein [Listeria monocytogenes EGD-e] lmo2026 [Listeria monocytogenes EGD-e], from CSGID

Results of FFAS03 search in PDB1018
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .
# Score Template Links and tools%idFirst MKKKFVYLLLLVLFMTVLPFQMLEAQAASTSWIEQELDGNEPFIAETEKILSKNRQDITLADLETIQKIHVFGADSIPNKISDYKNLTALEANYGTITEVPESVGSLKELVTLNVDENNLQEFPMVIFQLPKLEVLYISRGNITEIPTEITTLASHLKVLDVSNQKLVTIPDSILTTNWKAMHDGKLGMSLAGNQIASDIPANYLDNFNSGGNMLEFYDNPTIDYLQKQDQLTYTGGTIEVPLNTDFKQLTPDKTNLGLKSNIPLFSQHEFMYYDDGTSANILTNGVATDVGDGYITIKSTLSTNSNPFAKVRVPIKVTAPLKGADVTVQYLDSNGDTLATPDILSGNEGDAYASTPKTIDGYTLTQTPTNAQGTFTEEPQTVIYVYTKNSVAAAPVTVKYLNEEGKILTASDNLTGNVDDPYQTKAKEFAGYTLDESKLPTNASGVFKTNAQTVTYVYKTIPASIKAHDSTMNVGDTWSAKDNFDSAVDSLGVAVPFDEVKVDGSVDTTKAGVYPVTYSFAGDSVTIKVTVKATVVPAPPITPIKPVVPAPANPNTPSTQQTPTKQSGTLKIKATHQEQPIVAGNLKLPTTGDNLWDSVLYSIFGFITVCLSFVLFFRLKKQKNSLast
1 -48.6004u08_A mol:protein length:398 LIC11098  ali model follow..  13  19.PQNVRILNLSGSKLTTLPGEIGKLQNLQLLNLDDNIGKLQNLQQLHLSKNQLMALPEEIGQLQNLQKLKLNQLTAIPKEIGQLQNLQELNLAHNQLATLPEDIEQLQRLQTLYLGHNQFNSILKEIGQLQNLESLGLDHNQLNVLPKEIGQL-RNLESLGLDHNQLNVLPKEIGQLQNLQILHLRNNLTTLPKEIGQLQNLQKLLLNKNKLTTLPKEIGQLQNLQKLKLYENQLTT-----LPKEIGQLQNLQELDLDGNQLTTLPENIGQLQRLQTLYLGNNQLNFLPKEIGQLRNLESLDLEHNQLNALPKEIGKLQKLQTLNLKYNQLATLPEEIKQLKNLK----------KLYLHNNPLPSEKIARIRKLLP........................................................................................................................................................................................................................................................ 390
2 -48.5004u09_A mol:protein length:401 LIC12759  ali model follow..  14  18.PADVRNLDLSFQGLKTLPNKIGQLKNLQKLDLGGNIWQLKDLQKLNLNNNKLTVLPKEIGQLQNLQELSLNELVNLPKEIGQFKNLQKLNLDNNKLTVLPKEIGQLQNLQELSLLSNKLISLPTEIEQLKSLKNLDLNHNEFTTVSKEVMLL-ETLENLDLRSNKLKTIPKEIRQLKSLKVLMLTGNLTSLPKEIEQLQNLKTLNLGENRFQIFPVEILELKNLLELNLYYNQLVE-----FPKEVGQLKSLKYLSLYHNQITTLPVEVTQLPDLQELHLSGNKITILPKEILQLKNLEWLSLSNNKLNALPKEIGQLKKLQRLELGNNQLTTLPKEIEQLKNL----------QRLELDSNPISPKEKERIRKLLPKCE..................................................................................................................................................................................................................................................... 392
3 -48.2004u06_A mol:protein length:344 LIC10831  ali model follow..  17  12.PLEVRVLDLSRQELKTLPIEIGKLKNLQRLYLHYN---------------QLTVLPQEIEQLKNLQLLYLNRLTTLPKEIEQLKNLQVLDLGSNQLTVLPQEIGQLKNLQLLYLHSNRLTTLSKDIEQLQNLKSLDLSNNQLTTLPNEIEQL-KNLKSLYLSENQFATFPKEIGQLQNLKVLFLNNNITILPNEIAKLKKLQYLYLSDNQLITL----------------------------PKEIEQLKNLQTLDLSYNQLMILPKEVGQLENLQTLDLRNNQLKTLPKEIEQLKNLQTLFLSNNQLTILPQEIGKLKNLLWLSLVYNQLTTLPNEIEQLKNL----------QTLYLNNNQFSSQEKKRIRKLLPKCQ..................................................................................................................................................................................................................................................... 340
4 -43.5004b8c_D mol:protein length:727 GLUCOSE-REPRESSIBLE ALCOHOL DEHYDROGENASE TRANSCRIPTIONAL EFFECTOR  ali model follow..  5  1.......MNASTAAVNSIG-MVPTVGTPVNINVNASPLLHPHLDDPSLLNNPIWKLAAVSAQSLGQPNIYANAMKKYLATQQAQQAQQQAQQQAQQQVPGPFGPGPQAAPPALQPTDFQQSHIAEASKSLVDCTKQALMEMADTLTDSKTAKKQQLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDD---------------------------------------------IENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQ........................................................................................................................................................................................................................................................................................ 319
5 -42.5005zsu_A mol:protein length:818 Volume-regulated anion channel subunit LRRC8A  ali model follow..  11  325.YISLVIFYGLICMYTLWWMLRRSLKKYSFESIREEKNDFAFMLHLIDQYDPLYAVFLSEVSENKLRQLNLEWTLDKLRQRLTKNAQDKLELHLFMLSGIPDTVFDLVELEVLKLELIPDVTIPPSIAQLTGLKELWLYHTAAKIEAPALAFLRENLRALHIKFTDIKEIPLWIYSLKTLEELHLTGNRYIVIDGLRELKRLKVLRL----KSNLSKLPQVVTDVGVHLQKLSINNEGTKLIVLNSLKKMANLTELELIRCDLERIPHSIFSLHNLQEIDLKDNNLKTIEEIISHLHRLTCLKLWYNHIAYIPIQIGNLTNLERLYLNRNKIEKIPTQLFYCRKLRADIGLLQNLQNLAITANRIETLPPELFQKLRALHLGNNVLQSLPSRVGELTNLTQIELRGNRLECLPVELGECPL............................................................................................................................................................................................................. 778
6 -41.4004tzh_A mol:protein length:190 LIC12234  ali model follow..  21  17.PNEVQILDLSRNQLTILPKEIEQLVNLESLHLRDN---------------ELTTLPEEIGILKNLKYLDINQISNFPKEIQKLKNLEVLFLNGNSLSNLPEEIGELEKLGILYLNNNQLTTLPKEIGQLENLVSLSLSSNKLTSIPDELGQL-KKLRILNLWDNPTLTTPERIRKLFRNQEITIEIS...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 190
7 -41.4006fnw_A mol:protein length:417 Volume-regulated anion channel subunit LRRC8A  ali model follow..  14  5.ENKLRQLNLNNEWTLDKLRQRLTKNAQDKLELHLFVFDLVELEVLKLELIPDVTIPPSIAQLTGLKELWLYHKIEAPALAFLRENLRALHIKFTDIKEIPLWIYSLKTLEELHLTGNLSAEVIDGLRELKRLKVLRLK-SNLSKLPQVVTDVMVNLTELELIRCDLERIPHSIFSLHNLQEIDLKDNNLKTIEEIISFQHLHRLTCLKLWYNHIAYIPIQIGNLTNLERL--YLNRNKIEKIPTQLFYCRKLRYLDLSHNNLTFLPADIGLLQNLQNLAVTANRIEALPPELFQCRKLRALHLGNNVLQSLPSRVGELTNLTQIELRGNRLECLPVELGECPLL--------KRSGLVVEEDLFSTLPPEV.............................................................................................................................................................................................................................................................. 404
8 -39.5004ecn_A mol:protein length:876 Leucine-rich repeat protein  ali model follow..  11  423ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSELSWSNLKDLTDVELYMTQLPDFLYDLPELQSLNIADWTRLADDEDTGPKIQIFYMGYNNLEEFPASLQKMVKLGLLDCVHNKVRHLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPE----------------NSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFTTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRIL---RQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLY......................................................................................................................................................................................................................................................... 830
9 -37.7004fcg_A mol:protein length:328 uncharacterized protein  ali model follow..  12  5.SSGRENLYFQGTALRPYHDVLSQWQRHYNADRNRWQANSNNPQIETRTGRALKATADLLEDATGRVALELRPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRAPELTELPEPLASTLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSLSALGPAIHHLPKLEELDL--------------------------------------------------RGCTALRNYPPIFGGRAPLKRLILKDSNLLTLPLDIHRLTQLEKLDLRGVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE........................................................................................................................................................................................................................................................................................ 321
10 -37.1005hzl_B mol:protein length:303 Lmo2445 protein  ali model follow..  16  56.AIPLPSLGLTGEDLSVLNNEV--FTNAIELAIWSN---------------NIGELPDLSEALPALENIEAANITVFP--DANYPNLTNVDLSQNNFGFNIPKFVGMEGLVSINMENAGLSGYEDIWMNMPNLDSLILNENHLISIPEDIFLS-QQLGTHSFANQTATYPPTTIKQGENLKVFVPFIY...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 226
11 -36.3001m0z_A mol:protein length:290 Glycoprotein Ib alpha  ali model follow..  19  9.VASHLEVNCDKRQLTALPPDL---KDTTILHLSENLATLMPYTRLTQLNLDRCELTKVDGTLPVLGTLDLNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLALRGLGELQELYLKGNELKTLPPGLTPTPKLEKLSLANNQLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 205
12 -35.8005gr8_A mol:protein length:710 Leucine-rich repeat receptor-like protein kinase PEPR1  ali model follow..  13  190.SSSLQILYLHRNKLVSLPESLNLLGNLTTLFVGNNRFGSPNCKNLLTLDLSYNEVPPALGNCSSLDALVIVSGNTIPSSLGMLKNLTILNLSENRLSSIPAELGNCSSLNLLKLNDNQLVGIPSALGKLRKLESLELFENRFSEIPIEIWKS-QSLTQLLVYQNNLTELPVEMTEMKKLKIATLFNN-SFYGAIPPGLGVNSSLEEVDFIGNKLTGEIPPNLCHGRKLRILNLGSNLLHGTIPASIGHCKTIRRFILRENNLSGLLPEFSQDHSLSFLDFNSNNFEPIPGSLGSCKNLSSINLSRNRFTQIPPQLGNLQNLGYMNLSRNLLE----------SLPAQLSNCVSLERFDVGFNSLNGSVPSNFSNWKG----LTTLVLSENRFSGGIPQFLPE---KKLSTLQIARNAFGGEIPSSIGLIEDLIYDLDLSGNGLTGEIPAKLGDLIKL........................................................................................................................................................................ 649
13 -35.7003g06_A mol:protein length:622 SspH2 (Leucine-rich repeat protein)  ali model follow..  11  38LNNGNAVLNVGESGLTTLPDCL--PAHITTLVIPDNPALPPELRTLEVSGNQLTSLPVLPPGLLELSIFSNTHLPALPSGLCKLPGLQELSVSDNQLASLPALPSELCGLQELSVSDNQLASLPTLPSELYGLKELIVSGNRLTSLPVLP----SELKELMVSGNRLTSLPMLPSGLLSLSV--YRNQLTRLPESLIHLSSETTVNLEGNPLSER-----TLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQLAEDEALRANTFAMATEATSSCEDRVTF------HQMKNVQLVHNAEKGQYDNDLAALVATGREMFRLGKLEQIAREKVTLALVDEIEVWLAYQNKLKKSLGLTSVTSEMRFFDVSVTVTDLQDAELQVKAAEKSEFR.......................................................................................................................................................................... 533
14 -35.5005hyx_B mol:protein length:633 Probable LRR receptor-like serine/threonine-protein kinase At4g26540  ali model follow..  14  157.CENLVMLGLAETSLSKLPASIGNLKRVQTIAIYTSPDEIGYCTELQNLYLYQNSIPTTIGGLKKLQSLLLWQNNKIPTELGNCPELWLIDFSENLLTTIPRSFGKLENLQELQLSVNQISTIPEELTNCTKLTHLEIDNNLITEIPSLMSNL-RSLTMFFAWQNKLTNIPQSLSQCRELQAIDLSYN-SLSGSIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENRLVSIPPAISGCESLEFLDLHTNSLSGSLLGTTLPKSLKFIDFSDNALSTLPPGIGLLTELTKLNLAKNRLS----------EIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNRPSRFSDLKNLGVLDVSHNQL------TGNLNVLTDLQNLVSLNISYNDFSGDLPNTPFFRR................................................................................................................................................................................ 613
15 -35.4003p72_A mol:protein length:269 Platelet glycoprotein Ib alpha chain  ali model follow..  19  9.VASHLEVNCDKRQLTALPPDL---KDTTILHLSENLATLMPYTRLTQLNLDRCELTKVDGTLPVLGTLDLNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLALRGLGELQELYLKGNELKTLPPGLTPTPKLEKLSLANNQLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 205
16 -35.4004c2a_B mol:protein length:291 PLATELET GLYCOPROTEIN IB ALPHA CHAIN  ali model follow..  18  9.VASHLEVNCDKRRLTALPPDL---KDTTILHLSEN-ATLMPYTRLTQLNLDRCELTKVDGTLPVLGTLDLNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLALRGLGELQELYLKGNELKTLPPGLTPTPKLEKLSLANNRLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 205
17 -35.4004eco_A mol:protein length:636 Uncharacterized protein  ali model follow..  11  175.IKKSSRITLKDNNITFVSKAVMRLTKLRQFYMGNSNICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVPNLTKLPTFLKALPEMQLINVACNRGISGEQSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNDAKSVSVMSAIDFSYNEIGSDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK----------------NSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFTTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLR---EWPEGITLCPSLTQLQIGSNDIRKVNEKITPNIS......................................................................................................................................................................................................................................................... 590
18 -35.3001ook_G mol:protein length:290 Platelet glycoprotein Ib alpha chain precursor  ali model follow..  19  9.VASHLEVNCDKRNLTALPPDL---KDTTILHLSENLATLMPYTRLTQLNLDRAELTKVDGTLPVLGTLDLNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLALRGLGELQELYLKGNELKTLPPGLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 205
19 -35.3004z0c_A mol:protein length:709 Toll-like receptor 13  ali model follow..  12  82.LENLTLLNLVENKIQSVNNSFEGLSSLKTLLLSHNKDAFTPLIKLKYLSLSRNNISDAVQHLPCLERLDLNSIMYLDHSPRSLVSLTHLSFEGNKLRELNFSALSLPNLTNLSASRNGNKVINVYLKTLPQLKSLNLSGTVIKLENLSAKHLQNKLETLVFQKNVTNAEIKQLAKCTRLLFLDLGQNSDLIYLNDSEFNALPSLQKLNLNKCQLSFINNRTWSSLQNLTSLDLSHNKFKSFPDFAFSPLKHLEFLSLSRNPITELNLAFSGLFALKELNLAACWIVTIRYSFTQFPNLEVLDLGDNNIRTLHGTFRPLKKLQSLILSHNCLKILPNSFSGLTNL----------RSLDLMYNSLSYFHEHLFSGLEK--------------------LLILKLGFNKIT........................................................................................................................................................................................................................ 509
20 -35.1005jfi_A mol:protein length:613 Leucine-rich repeat receptor-like protein kinase TDR  ali model follow..  10  75.LSSLLYLNLSGNSLESFPTSIFDLTKLTTLDISRNPPGISKLKFLKVFNAFSNNLPSDVSRLRFLEELNFGGSYEIPAAYGGLQRLKFIHLAGNVLGKLPPRLGLLTELQHMEIGYNHFNNIPSEFALLSNLKYFDVSNCSLSSLPQELGNL-SNLETLFLFQNGFTEIPESYSNLKSLKLLDFSSN-QLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPELTTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTTIPSSLCHGNKLYKLILFSNMFEELPKSLTRCESLWRFRSQNNRLNTIPIGFGSLRNLTFVDLSNNRFT----------QIPADFATAPVLQYLNLSTNFFHRKLPENIWKAPNLQISFSNLIGEIPNYVGCKSFYRIELQGNSL------NGTIPWDI-GHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTITTFNVSYNQLIGPI...................................................................................................................................... 571
21 -34.8005gij_B mol:protein length:607 Leucine-rich repeat receptor-like protein kinase TDR  ali model follow..  10  74.LSSLLYLNLSGNSLESFPTSIFDLTKLTTLDISRNPPGISKLKFLKVFNAFSNNLPSDVSRLRFLEELNFGGSYEIPAAYGGLQRLKFIHLAGNVLGKLPPRLGLLTELQHMEIGYNHFNNIPSEFALLSNLKYFDVSNASLSSLPQELGNL-SNLETLFLFQNGFTEIPESYSNLKSLKLLDFSSN-QLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPELTTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTTIPSSLCHGNKLYKLILFSNMFEELPKSLTRCESLWRFRSQNNRLNTIPIGFGSLRNLTFVDLSNNRFT----------QIPADFATAPVLQYLNLSTNFFHRKLPENIWKAPNLQISFSNLIGEIPNYVGCKSFYRIELQGNSL------NGTIPWDI-GHCEKLLSLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTITTFNVSYNQLIGPI...................................................................................................................................... 570
22 -34.6004bsr_A mol:protein length:539 LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 5  ali model follow..  11  51LSVFTSYLDLSMNNISQLLPNLPSLRFLEELRLAGNKGAFTGLYSLKVLMLQNNQLTEALQNLRSLQSLRLNHISYVPPSFSGLHSLRHLWLDDNALTEIPVAFRSLSALQAMTLALNKIHHIPDAFGNLSSLVVLHLHNNRIHSLGKKCFDGLHSLETLDLNYNNLDEFPTAIRTLSNLKELGFHSN-NIRSIPEKAFVGNPSLITIHFYDNPIQFVGRSAFQHLPELRTLTLNGASQITEFPDLTGTANLESLTLTGAQISSLPQTVCNQLPNLQVLDLSYNLLEDLP-SFSVCQKLQKIDLRHNEIYEIKVTFQQLLSLRSLNLAWNKIAIIHPNA---------FSTLPSLIKLDLSSNLLSSFPITGLHGLTHTGNHALQSLISSENFPELKVIEMPYAYQCCAFG--------ENAYKISNQWNKGDNSSMDDLHKKDAGMFQA................................................................................................................................................................................ 503
23 -34.5004mn8_A mol:protein length:782 LRR receptor-like serine/threonine-protein kinase FLS2  ali model follow..  14  191.LANLTDLDLSGNQLTKIPRDFGNLLNLQSLVLTENPAEIGNCSSLVQLELYDNQIPAELGNLVQLQALRIYKNKSIPSSLFRLTQLTHLGLSENHLVPISEEIGFLESLEVLTLHSNNFTEFPQSITNLRNLTVLTVGFNNISELPADLGLL-TNLRNLSAHDNLLTPIPSSISNCTGLKLLDLSHNQM--TGEIPRGFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTPIPREIGNLKDLNILYLHSNGFTRIPREMSNLTLLQGLRMYSNDLEPIPEEMFDMKLLSVLDLSNNKFSQIPALFSKLESLTASLKSLSLLNTFDISDNLLTTIPGELLASLKNMQLYLNFSNNLPKELGKLEMVQEIDLSNNLFSSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLM....................................................................................................................... 753
24 -34.3003oja_A mol:protein length:487 Leucine-rich Immune Molecule 1  ali model follow..  13  33.AWNVKELDLSGNPLSQIAADLAPFTKLELLNLSSNTLDLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHANNISRVSCSEGCRSRVQYLDLKLNEIDTVNELAASSDTLEHLNLQYNFIYDVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSA-AGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNQTVAKQTVKKLTGADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLR--KQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDEENARLKKLNGEADLALASANATLQELVVRENLASQLG............................................................................................................................................................................................................................................................ 487
25 -34.2004ufr_A mol:protein length:484 LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 5  ali model follow..  12  36LSVFTSYLDLSMNNISQLLPNLPSLRFLEELRLAGN-GAFTGLYSLKVLMLQNNQLRHALQNLRSLQSLRLNHISYVPPSFSGLHSLRHLWLDDNALTEIPVQFRSLSALQAMTLALNKIHHIPDAFGNLSSLVVLHLHNNRIHSLGKKCFDGLHSLETLDLNYNNLDEFPTAIRTLSNLKELGFHSN-NIRSIPEKAFVGNPSLITIHFYDNPIQFVGRSAFQHLPELRTLTLNGASQITEFPDLTGTANLESLTLTGAQISSLPQTVCNQLPNLQVLDLSYNLLEDLP-SFSVCQKLQKIDLRHNEIYEIKVTFQQLLSLRSLNLAWNKIAIIHPNA---------FSTLPSLIKLDLSSNLLSSFPITGLHGLTHLKLTGNHALQSLISSENFPELKVIEMPYAYQCC....................................................................................................................................................................................................................... 452
26 -34.0004kng_A mol:protein length:531 Leucine-rich repeat-containing G-protein coupled receptor 5  ali model follow..  11  35LSVFTSYLDLSMNNISQLLPNLPSLRFLEELRLAGN-GAFTGLYSLKVLMLQNNQLRHALQNLRSLQSLRLNHISYVPPSFSGLHSLRHLWLDDNALTEIPVQFRSLSALQAMTLALNKIHHIPDAFGNLSSLVVLHLHNNRIHSLGKKCFDGLHSLETLDLNYNNLDEFPTAIRTLSNLKELGFHSN-NIRSIPEKAFVGNPSLITIHFYDNPIQFVGRSAFQHLPELRTLTLNGASQITEFPDLTGTANLESLTLTGAQISSLPQTVCNQLPNLQVLDLSYNLLEDLP-SFSVCQKLQKIDLRHNEIYEIKVTFQQLLSLRSLNLAWNKIAIIHPNA---------FSTLPSLIKLDLSSNLLSSFPITGLHGLTHTGNHALQSLISSENFPELKVIEMPYAYQCCAFG....................................................................................................................................................................................................................... 454
27 -33.8004mna_A mol:protein length:662 LRR receptor-like serine/threonine-protein kinase FLS2  ali model follow..  14  95.LTELQSLVLTENLLEDIPAEIGNCSSLVQLELYDNPAELGNLVQLQALRIYKNKLPSSLFRLTQLTHLGLSENHPISEEIGFLESLEVLTLHSNNFTEFPQSITNLRNLTVLTVGFNNISELPADLGLLTNLRNLSAHDNLLTPIPSSISNC-TGLKLLDLSHNQMTEIPRGFGRMNLTFISIGRNH--FTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTRIPREMSNLTLLQGLRMYSNDLEPIPEEMFDMKLLSVLDLSNNKFSQIPALFSKLESLTYLSLQGNKFN----------SIPASLKSLSLLNTFDISDNLLTTIPGELLASLKNMQLYLNFSNNLPKELGKLEMVQEIDLSNNLFSSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHV...................................................................................................................................... 618
28 -33.6005iyx_A mol:protein length:658 Receptor-like protein kinase 5  ali model follow..  12  124.LPNLKFLEISGNNLSTIPSSFGEFRKLESLNLAGNPASLGNVTTLKELKLAYNLIPSQLGNLTELQVLWLAGCNPIPPSLSRLTSLVNLDLTFNQLTSIPSWITQLKTVEQIELFNNSFSELPESMGNMTTLKRFDASMNKLTKIPDNLN--LLNLESLNLFENMLEPLPESITRSKTLSELKLFNN-RLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSQIPHGFWGLPRLSLLELSDNSFTSIPKTIIGAKNLSNLRISKNRFSSIPNEIGSLNGIIEISGAENDFSEIPESLVKLKQLSRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYSSNQFSGEIPLELQNLKLNVLNLSYNHL------SGKIPPLY........................................................................................................................................................................................................... 576
29 -33.6004kt1_A mol:protein length:504 Leucine-rich repeat-containing G-protein coupled receptor 4  ali model follow..  13  30LSAFTQALDISMNNITQLPEDFKNFPFLEELQLAGNPKALSGLKELKVLTLQNNQLKTAIRGLSALQSLRLNHITSVPEDFEGLVQLRHLWLDDNSLTEVPVPLSNLPTLQALTLALNKISSIPDAFTNLSSLVVLHLHNNKIRSLSQHCFDGLDNLETLDLNYNNLGEFPQAIKALPSLKELGFHSN-SISVIPDGAFDGNPLLRTIHLYDNPLSFVGNSAFHNLSDLHSLVIRGASMVQQFPNLTGTVHLESLTLTGTKISSIPNNLCQEQKMLRTLDLSYNNIRDLP-SFNGCHALEEISLQRNQIYQIKETFQGLISLRILDLSRNLIHEIHSRA---------FATLGPITNLDVSFNELTSFPTEGLNGLNQLKLVGNFKLKEALAAKDFVNLRSLSVPYAYQCCA------------WGCDSYANLNTEDNSLQDHSVAQEKGTADAANVTSTLENEE................................................................................................................................................................. 489
30 -33.6004r6g_A mol:protein length:464 leucine rich repeats DLRR_K  ali model follow..  12  39.LNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNISALKELTNLGWLNLSNNQLQGVFEKLTNLTTLNLNQLTSLPQGFERLASLTTLNLSNNNLANLDRVFEGLTNLTTLNLSNNNLARLWKHLKGLTNLTTLNLSNNGFDELPKEVFKDLTSLTTLNLSNNQLTSLPQGFERLTNLTTLNLSNN-QLTSLPQGVFERLTNLTTLNLSNNQLTSLPQGVFERLTSLTTLNLSNNQLTSLPKGVLERLTNLKTLNLSNNQITKEAELLKQAASLHELHLSNNNIGEEEALLHPGSTLETLDLSNCNLTEIARALKQATTLHELHLSNNNI----GEEGAAELVEALLHPGSTLETLDLSNCNLTKEACRE-----------------ARALKQATSLHELHLSNNNIGS....................................................................................................................................................................................................................... 464
31 -32.8004qxe_A mol:protein length:443 Leucine-rich repeat-containing G-protein coupled receptor 4, linker, Variable lymphocyte receptor B  ali model follow..  12  31LSAFTQALDISMNNITQLPEGFKNFPFLEELQLAGNPKALSGLKELKVLTLQNNQLKTAIRGLSALQSLRLNHITSVPEDFEGLVQLRHLWLDDNSLTEVPVHLSNLPTLQALTLALNKISSIPDAFTNLSSLVVLHLHNNKIRSLSQHCFDGLDNLETLDLNYNNLGEFPQAIKALPSLKELGFHSN-------------------------SISVIPDGAFDGNPLLRTIHLYDNPLSFVGNSAFHNLSDLHSLVIRGASMVQQFPNLTGTVHLESLTLTGTKISSIPNNLQEQKMLRTLDLSYNNIRDLPS-FNGCHALEEISLQRNQIYQIKEGT---------FQGLISLRILDLASNQLKSVPDGIFDRLTSLQK..................................................................................................................................................................................................................................................... 393
32 -32.7003rfs_A mol:protein length:272 Internalin B, repeat modules, Variable lymphocyte receptor B  ali model follow..  13  40.LNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNISALKELTNLTYLILTGNQLQSVFDKLTNLKELVLNQLQSLPDGFDKLTNLTYLNLAHNQLQSLPKGFDKLTNLTELDLSYNQLQSLPEGFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWINK........................................................................................................................................................................................................................................................................................................................................................................................................................................................... 233
33 -32.6004j4l_A mol:protein length:267 Internalin B,REPEAT MODULES,Variable lymphocyte receptor B  ali model follow..  11  33.LNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNISALKELTNLTYLTLEPNQLQSVFDKLTNLKELQLNQLQSLPDGFDKLTNLTYLNLAFNQLQSLPKGFDKLTNLTELDLSYNQLQSLPKGFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWINK---HSGVVRNSAGSVAPDSAKCSGSGKPVRSII.......................................................................................................................................................................................................................................................................................................................................................................................................................... 256
34 -32.4005kzs_A mol:protein length:340 Putative cell surface protein, similar to internalin proteins  ali model follow..  13  45.LDALTGLTITNDSMQLLERAMFNNVNIVSVMEFGEFPDISTIPHLNTLFFNTPPELPDYQNYPEMVTITMSNLIGAIPDFTGMPDLSQLYMADMMITSDVPDFHTIPKLSTLDLSHNQLTNLP-DFQNLTNLAELNLSFNNLTNTMTNFTNL-SNLNNLNLDYNHLNELPSNVLNS-----IFIENQSGTVPDQIIKQGETCTIQL---------------------------------------------------------PIYFQLAEINMLVNPTVLGSYSADIPVEVVTTTNADTESITLDTSELSP-------GVYNFNVQFNDAYPITQEGCVYDWVL........................................................................................................................................................................................................................................................................................ 337
35 -32.4004nkg_A mol:protein length:246 E3 ubiquitin-protein ligase sspH1  ali model follow..  19  34LNNGNPVLNVGASGLTTLPDRLPP--HITTLVIPDN---------------NLTSLPELPEGLRELEVSGNLQLTSLPSLPQGLQKLWAYNNWLASLPTLPPGLGDLAALRELRVSGNNLTSLPALPS---GLQKLWAYNNRLTSLPEMS----PGLQELDVSHNQLTRLPQSLTGLSSAARVYLDGN...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 211
36 -32.1005gmf_A mol:protein length:817 Toll-like receptor 7  ali model follow..  14  104.LTYLKSLYLDGNQLLEIPQGL--PPSLQLLSLEANKEQLTELANIEILYLGQNCYKDAFLNLTKLKVLSLNNVTTVPTVL--PSTLTELYLYNNMIAEIEDDFNNLNQLQILDLSGNCPRCYVNAFDALTELKVLRLHSNSLQHVPPRWFKNINNLQELDLSQNFLAKEIGDLHFLPNLIQLDLSFNFELQSQAFSSLKSLKILRIRGYVFKELKSFQLSPLHNLQNLEVLDLGTNFIKIANLSMFKQFKRLKVIDLSVNKISPSGDSSFRYDKYARSCRFKNKEASFSVQESCYKYGQTLDLSKNSIFFISSDFQHLSFLKCLNLSGNLISQT-QPLAELRYLSTAFEELRKLEVLDISSNSHYFQSEGITHVLQKLMMNDNDISSSTSRTMESESLRTLEFRGNHLDVLWRDGDNRYLQLFKNLLKLEELDISKNSLSFLPSGVFDGMPPNLKNL........................................................................................................................................................................ 658
37 -32.0005zln_A mol:protein length:793 Toll-like receptor 9  ali model follow..  12  97.MRTLEELNLSYNGITTVPRLPSSLVNLS---LSHTANSLAGLYSLRVLFMDGNCYPGALLGLSNLTHLSLNNLTKVPRQL--PPSLEYLLVSYNLIVKLPEDLANLTSLRVLDVGGNCRRCHPETFHHLSHLEGLVLKDSSLHTLNSSWFQGLVNMSVLDLSENFLYESTNAFQNLTRLRKLNLSFNYRKKASSFKNLVSLQELNMNGIFFRSLNKYTLRWLADLPKLHTLHLQMNFINQAQLSIFGTFRALRFVDLSDNRISGPSTLSEATPEEADDAEQEELLSADPHPAP--NFKFTMDLSRNNLVTIPEMFVQLSRLQCLSLSHNSIAQA-LPLTNLQVLDKSFSELPQLQALDLSYNSQPFSMKGIGHMLHSLSLAHNDIHTRVSSHLNSNSVRFLDFSGNGMGRMWDEGGLYLHFFQ-GLSGLLKLDLSQNNLHILRPQNLDNLPKSLKLL........................................................................................................................................................................ 634
38 -31.9004li1_B mol:protein length:432 Leucine-rich repeat-containing G-protein coupled receptor 4  ali model follow..  13  15.CDLDGGADCSGKGLVTVPDGL--SVFTHSLDLSMN-GAFKGFPYLEELRLAGNDLSIALSGLKELKVLTLNQLKTVPSELKGLVSLQSLRLDANHIVTVPESFEGLVQLRHLWLDDNSLTEVPIRLSNLPSLQALTLALNKISHIPDYAFSNLSSLVVLHLHNNKIRTLGPHFHGLDNLEALDLNYNNLID----DSIRSLPNLKELGFHSNSITIIPDGAFVKNPLLRTIHLYDNPLSFVGNSAFQNLSDLHFLIIRGASNVQWFPNLTGTNNLESLTLTGTKIRSIPIKFQEQKMLRTLDLSYNEISALVG-FEGCSSLEEVYLQNNQIQEVQNET---------FQGLAALRMLDLSRNRIHTIHKEAFVTLKALTNLDLSFNDLTAFPTAGLHLNQLKLTGNPNFK....................................................................................................................................................................................................................... 428
39 -31.9003a79_A mol:protein length:580 Toll-like receptor 2, Variable lymphocyte receptor B  ali model follow..  11  30.CDASGVCDGRSRSFTSIPSGL--TAAMKSLDLSFN--KITYIG------------HGDLRACANLQVLILSRINTIGDAFYSLGSLEHLDLSDNHLSSLSSSFGPLSSLKYLNLMGNPYQTLGSLFPNLTNLQTLRIGNVEFSEIRRIDFAGLTSLNELEIKALSLRNYSQSLKSIRDIHHLTLHLS-ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSFYDLSTVYSLLEKVKRITVENSKVFLVPSFSQHLKSLEFLDLSENLMVESQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNL-----------DSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKIASNQLKS.................................................................................................................................................................. 513
40 -31.9005b4p_A mol:protein length:261 repebody  ali model follow..  13  42.LNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNISALKELTNLTYLFLDFNQLQLVFDKLTNLKELYLNQLQSLPDGFDKLTNLTILGLDMNQLQSLPKGFDKLTNLTELDLSYNQLQSLPKGFDKLTQLKDLSLSYNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWIN............................................................................................................................................................................................................................................................................................................................................................................................................................................................ 233
41 -31.9005b0n_A mol:protein length:224 E3 ubiquitin-protein ligase ipaH9.8  ali model follow..  16  34LINNSDELRLDRLNLSSLPDNLPTLLNVSYNQLTNLPELPVTLKKLYSASNKLSELPVLPPALESLQHNELENLPALPD------SLLTMNISYNEIVSLPSLPQ---ALKNLRATRNFLTELPASEGNNPVVREYFFDRNQISHIPESILNL-RNECSIHISDNPLSSHA--LPALQRLTSSPDYHG...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 215
42 -31.8003oja_B mol:protein length:597 Anopheles Plasmodium-responsive Leucine-rich repeat protein 1  ali model follow..  11  21.SNLQYDCVFYDVHIDMQTQDV-TLNNQKIVTFKNS--TMRKLP------------AALLDSFRQVELLNLLQIEEIDTYFAYAHTIQKLYMGFNAIRYLPPHFQNVPLLTVLVLERNDLSSLPRGFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSL--------IPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLN----------------------------YPGLVEVDLSYNELEKIMYPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRL----------ENLYLDHNSIVTLKLSTHHTLKN........................................................................................................................................................................................................................................................ 349
43 -31.8004qxf_A mol:protein length:301 Leucine-rich repeat-containing G-protein coupled receptor 4, Variable lymphocyte receptor B  ali model follow..  15  31LSAFTQALDISMNNITQLPEGFKNFPFLEELQLAGNPKALSGLKELKVLTLQNNQLKTAIRGLSALQSLRLNHITSVPEDFEGLVQLRHLWLDDNSLTEVPVHLSNLPTLQALTLALNKISSIPDAFTNLSSLVVLHLHNNKIRSLSQHCFDGLDNLETLDLNYNNLGEFPQAIKALPSLKELALDTNKSVPDGIFDRLTSLQKIWLHTN................................................................................................................................................................................................................................................................................................................................................................................................................................ 258
44 -31.7005ufb_A mol:protein length:248 Tn4-22  ali model follow..  17  10...RGTYVDCDSRRLASVPAGI--PTNVQILNLYNNPGVFDRLVNLQKLYLSGNQLQAVFDKLSQLTFLSLNKLTALPNGFDKLTELTYLNLNTNQLTALPEVFDRLVHLKELLMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRDIMYLRNWVA............................................................................................................................................................................................................................................................................................................................................................................................................................................................ 200
45 -31.6003rfj_A mol:protein length:279 Internalin B, repeat modules, Variable lymphocyte receptor  ali model follow..  15  40.LNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNISALKELTNLTYLILTGNQLQSVFDKLTNLKELVLNQLQSLPDGFDKLTNLTYLYLYHNQLQSLPKVFDKLTNLTRLDLDNNQLQSLPEGFDKLTQLKQLSLNDNQLKSVPDGVFDRLTSLTHIWLLNNPWDCACSDI.................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 224
46 -31.5002z7x_A mol:protein length:549 Toll-like receptor 2, Variable lymphocyte receptor B  ali model follow..  11  24LTEAVKSLDLSNNRITYISNSLQRCVNLQALVLTSNEDSFSSLGSLEHLDLSYNYLSSWFKPLSSLTFLNLNPYKTLGETFSHLTKLQILRVGNMDTFT-RKDFAGLTFLEELEIDASDLQSYPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFFSELSTGETNSLIKKFTFRNISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLQHLKSLEYLDLSENLMVEESACEDAWPSLQTLILRQNHLASLEKTLLTLKNLTNIDISKNSFHSMPETCQWPEKMK----------YLNLSSTRIHSVTGCIPKTLEILDVSNNNL---NLFSLNLPQLKELYISRNKLMTLPDAS-----------PMLLVLKISRNQLKSVPDGIFDRLTSLQKIWLHTNP................................................................................................................................................................... 508
47 -31.5004puf_A mol:protein length:637 E3 ubiquitin-protein ligase SlrP  ali model follow..  12  105LPDTIQEMELSINRITELPERLPS--ALQSLDLFHN-NLPEELRYLSVYDNSIRTLPAHL--PSEITHLNVNSLTALPETL--PPGLKTLEAGENALTSLPASL--PPELQVLDVSKNQITVLPETLP--PTITTLDVSRNALTNLPE---NLPAALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFSERTIQNMQRLMSSVDYQGPRVLFAMGDFSIVRVTRPLHQAVQGWLTSLEEEDVNQWRAFEAEANAAAFSGFLDYLGDTQN-----------TRHPDFKEQVSAWLMRLAEDSALRETVFIIAMNATISCEDRVTLAYHQMQSHLAELIMAGREIFRLEQIESLAREKVKRLFFIDEV---------EVFLGFQNQSLTTMTRDMRFYNVSG---ITESDLDEAEIRIKMAENRDFHKWFALHKVLERIAPEEWREMMAKRDECIETDE................................................................................................................................................................... 562
48 -31.5005d3i_A mol:protein length:568 Toll-like receptor 2  ali model follow..  11  28LTAAMKSLDLSFNKITYIHGDLRACANLQVLILKSSGDAFYSLGSLEHLDLSDNHLSSWFGPLSSLKYLNLNPYQTLGSLFPNLTNLQTLRIGNVEFSEIRRDFAGLTSLNELEIKALSLRNYSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFQHLKSLEFLDLSENLMVEESACKGAWPSLQTLVLSQNHLRSMQKILLTLKNLTSLDISRNTFHPMPDSCQWPEKM----------RFLNLSSTGIRVVKTCIPQTLEVLDVSNNNL---DSFSLFLPRLQELYISRNKLKTLPDASL----------PVLLVMKIRENAVSTFSKDQLGSFPKLETLEAGDNH................................................................................................................................................................... 512
49 -31.4004u7l_A mol:protein length:456 Leucine-rich repeats and immunoglobulin-like domains protein 1  ali model follow..  14  52.LPNLQEVYLNNNELTAVPSLGAASSHVVSLFLQHN-SQLKAYLSLEVLDLSLNNITECFPHGPPIKELNLNRIGTLELGAGLSRSLLTLRLSKNRITQLPVRAFKLPRLTQLDLNRNRIRLIEGTFQGLNSLEVLKLQRNNISKLTDGAFWGLSKMHVLHLEYNSLVEVNSGLYGLTALHQLHLSNN-SIARIHRKGWSFCQKLHELVLSFNNLTRLDEESLAELSSLSVLRLSHNSISHIAEGAFKGLRSLRVLDLDHNEISGTIEDTSGLDSLSKLTLFGNKIKSVAKAFSGLEGLEHLNLGGNAIRSVQFAFVKMKNLKELHISSDSFLCDCQLKWLPPWLIGRMLQAFVAHPESLKGQSIFSVPPESFVCDDFLKA..................................................................................................................................................................................................................................................... 456
50 -31.3005mx0_A mol:protein length:362 Fibromodulin  ali model follow..  10  22.STSSDPSDPSPSETSEPPSGVDEGPASTSGSPSPP-CPPNFPTAMYCDNRNLKYLPFVPSRMKYVY-FQNNQITSIQEGFDNATGLLWIALHGNQITSDRKVFSKLRHLERLYLDHNNLTRMPGPL--PRSLRELHLDHNQISRVPNNALEGLENLTALYLQHNEIQEVGSSMRGLRSLILLDLSYNHLRK-----PDGLPSALEQLYMEHNNVYTVPDSYFRGAPKLLYVRLSHNSLTNN----------------------GLASNTFNSSSLLELDLSYNQLQKIPPVNTNL---ENLYLQGNRINEFSIDVVNFSKLQVLRLDGNEIKRSAMPADAPLCLR........................................................................................................................................................................................................................................................................................ 355
51 -31.3005uei_A mol:protein length:249 O13  ali model follow..  13  10...SGTTVNCKSKSLASVPAGI---TTTRVLYLNDNPGVFDRLVNLQTLWLNNNQLTSLFDSLTQLTILALNQLQALPVGFGRLVDLQQLYLGSNQLSALPSVFDRLVHLKELLMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRDIMYLRNWVA............................................................................................................................................................................................................................................................................................................................................................................................................................................................ 200
52 -31.3005hl3_A mol:protein length:361 Lmo2470 protein  ali model follow..  15  74.VTDVSIMEFGAKLTEPDITTIPHLKTLFFADPPGRLPNYQNYPEMDTITMSGNNLIGSIPDFTGMPALKQLYMSEELPNFNNIPLLITLDLSSNQLTTIP-DFQNIPNLTFLDLNANLLTNTP-DFQNLPKLTDLNLRHNNLTGTMVNYTNL-PSLESLNLDYNFLTELPSNVLDTIYVQ............................................................................................................................................................................................................................................................................................................................................................................................................................................................. 263
53 -31.3004uip_B mol:protein length:251 REPEBODY (RAC1)  ali model follow..  14  1....METITVSTPIKQIFPDDQNELNSIDQIIANNSVQGIQYLPNVRYLALGGNKLHDALKELTNLTYLMLNQLQILPNGFDKLTNLKELYLSENQLQSLPDGFDKLTNLTELDLARNQLQSLPKGFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWINK........................................................................................................................................................................................................................................................................................................................................................................................................................................................... 210
54 -31.2004pq8_A mol:protein length:271 DESIGNED PROTEIN OR465  ali model follow..  16  41.LNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNISALKELTNLGWLNLSNNQLETVFEKLTNLTTLNLNQLTSLPQGFERLASLTTLNLSNNQLTSLPQGFERLTNLTTLNLSNNQLTSLPQGFERLTNLTTLNLSNNQLTSLPQGVFERLTSLTTLNLSNNQLTSLPQGFERLTNLKTLNLSNN...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 240
55 -31.1003wpb_A mol:protein length:802 Toll-like receptor 9  ali model follow..  13  41.RDNVTSLSLLSNRIHHLDSDFAQLSNLQKLNLKWN--CPPAGLSPMHFPCHMTIEPNTFLAVPTLEELNLNGITTVPALP---SSLVSLILSRTNILQLPTSLTGLHALRFLYMDGNCYYKAPGALLGLGNLTHLSLKYNNLTTVPR---SLPPSLEYLLLSYNHIVTLPEDLANLTALRVLDVGGNCKFPQLHSDTFSHLSRLEGLVLKDSSLYQLNPRWFRGLGNLTVLDLSENFLYDCITKAFQGLAQLRRLNLSFNYHKTLAPSFGSLLSLQELDMHGIFFRSLSQPLARLPMLQRLYLQMNFINQALGIFKDFPGLRYIDLSDNRISGAVEPVATTGEVDG-------GKKVWLTSRDLTPGPLDTPSSEDFMPSCKNLSFTLDEMFAQLSRLQCLRLSHNSI------SQAVNGSQFVPLTSLQVLDLSHNKLDLYHGRSFTE................................................................................................................................................................................ 522
56 -30.9003wpe_A mol:protein length:801 Toll-like receptor 9  ali model follow..  12  101.VPTLEELNLSYNGITTVPALPSSLVSLS---LSHTPTHFTGLHALRFLYMDGNCYPGALLGLGNLTHLSLNNLTEVPRRL--PPSLDTLLLSYNHIVTLPEDLANLTALRVLDVGGNCRRCHPDTFSHLSRLEGLVLKDSSLYKLEKDWFRGLGRLQVLDLSENFLYDYTTIFNDLTQLRRLNLSFNYHKLASSFGSLVSLEKLDMHGIFFRSLTNITLQSLTRLPKLQSLHLQLNFINQAQLSIFGAFPSLLFVDLSDNRISGAATPAAALGEVDSRVEVWRLPRGLAPGMPSCNLNFTLDLSRNNLVTIQEMFTRLSRLQCLRLSHNSISQAGSQFVPLTSLRRSFTELPQLEALDLSYNSQPFSMQGVG-SLRYLSLAHNGIHSRVSQKLSSASLRALDFSGNSLSQMWA-EGDLYLCFFKGLRNLVQLDLSENHLHTLLPRHLDNLPKSLRQL........................................................................................................................................................................ 636
57 -30.9003o53_A mol:protein length:317 Protein LRIM1  ali model follow..  13  57.FTKLELLNLSSNVLYETL-DLESLSTLRTLDLNNNVQELLVGPSIETLHAANNNISVSCSRGQGKKNIYLNKITMLRDDEGCRSRVQYLDLKLNEIDTVNELAASSDTLEHLNLQYNFIYDVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSA-AGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGN...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 247
58 -30.8003t6q_A mol:protein length:606 CD180 antigen  ali model follow..  11  11.KEVNKTYNCENLGLNEIPGTL--PNSTECLEFSFNNTTFSRLINLTFLDLTRCQIEDTFQSQHRLDTLVLNPLIFMAETLSGPKALKHLFFIQTGISSIFIPLHNQKTLESLYLGSNHISSILPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATSLNLNGNDIAGIEPGADSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLQISASNFPSLTHLSIKGNTKRLETGCLENLENLRELDLSHD-------DIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD........................................................................................................................................................................................................................ 438
59 -30.8004r6j_A mol:protein length:254 Lucine rich repeats DLRR_H  ali model follow..  16  39.LNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNISALKELTNLGWLNLSNNQLETVFEKLTNLTTLNLNQLTSLPQGFERLASLTTLNLSNNNLANLNDKFEGLTNLTTLNLSNNNLARLWKHLKGLTNLTTLNLSNNGFDEFPKEVFKDLTSLTTLNLSNNQLTSLPQGFERLTNLKTLNLSNN...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 246
60 -30.7003wpf_A mol:protein length:803 Toll-like receptor 9  ali model follow..  12  101.MRTLEELNLSYNGITTVPRLPSSLVNLS---LSHTANSLAGLYSLRVLFMDGNCYPGALLGLSQLTHLSLNNLTKVPRQL--PPSLEYLLVSYNLIVKLPEDLAQLTSLRVLDVGGNCRRCHPETFHHLSHLEGLVLKDSSLHTLNSSWFQGLVQLSVLDLSENFLYESTNAFQNLTRLRKLNLSFNYRKKASSFKNLVSLQELNMNGIFFRLLNKYTLRWLADLPKLHTLHLQMNFINQAQLSIFGTFRALRFVDLSDNRISGPSTEQEELLSADPHPAPLSTPASKNFMDRCKNFKFTMDLSRNNLVTIPEMFVQLSRLQCLSLSHNSIAQA-LPLTNLQVLDKSFSELPQLQALDLSYNSQPFSMKGIGSMLQSLSLAHNDIHTRVSSHLNSNSVRFLDFSGNGMGRMWDEGGLYLHFFQ-GLSGLLKLDLSQNNLHILRPQNLDNLPKSLKLL........................................................................................................................................................................ 638
61 -30.7004z5w_A mol:protein length:642 Phytosulfokine receptor 1  ali model follow..  13  86.LDQLKVLNLTHNSLSSIAASLLNLSNLEVLDLSSNFPSLINLPSLRVLNVYENSFHGLINNLPRIREIDLAMNYSIPVGIGNCSSVEYLGLASNNLSSIPQELFQLSNLSVLALQNNRLSALSSKLGKLSNLGRLDISSNKFSKIPDVFLEL-NKLWYFSAQSNLFNEMPRSLSNSRSISLLSLRNN-TLSGQIYLNCSAMTNLTSLDLASNSFSGSIPSNLPNCLRLKTINFAKIKFIAQIPESFKNFQSLTSLSFSNSSIQSALEILQHCQNLKTLVLTLNFQKTVPQWLSNSPSLQLLDLSWNQLSTIPPWLGSLNSLFYLDLSNNTFIEIPHSLTSLQSLVSKENAVEEPSMIDLSYNSLNGSIWPEFGDL----RQLHVLNLKNNNLSGNISLEVLDLSHNNL------SGNIPPSLV-KLSFLSTFSVAYNKLSGPTGVQFQTFPNS............................................................................................................................................................................ 610
62 -30.6003jqh_A mol:protein length:167 C-type lectin domain family 4 member M  ali model follow..  15  3.LPEKSKLQEIYQELTRLKAAVGELPEKSKLQEIYQ---------------ELTRLKAAVGELPEKSKLQEQELTRLKAAVGELPEKSKLQEIYQELTRLKAAVGELPEKSKLQEIYQELTELKAAVGELPEKSKLQEIYQELTQLKAAVGEL-PDQSKQQQIYQELTDLKTAFERLGH............................................................................................................................................................................................................................................................................................................................................................................................................................................................... 166
63 -30.6003rg1_A mol:protein length:612 CD180 molecule  ali model follow..  10  10.KEGNRTYNCENLGLREIPDTLPN--TTEVLEFSFN--FLPTIQ------------NTTFSRLINLIFLDLCQINWVEDTFQSHHQLNTIVLTGNPLIFMETSLTGPKFLKHLFLTQTGISNLFIPVHNLENLESLHLGSNHISSINLPENFPTQNLKVLDFQNNAIHYISRKLEQATNLSLNFNGNDIKGIEPGAFISKIFQSLK-FGGSLNLFIIFKGLQNSTLQSLWLGTFEDTDDQYLTSATFEGLCDMSVESQKHRFSDLSSSTFRCFTRVQELDLTAAHLNGLPSGIEGMNSLKKLVLNANSFDQLQINAASFPSLRDLYIKGNKLDLSHSDIEASDCCNLQLKNLRHLQYLNLSYNEPLGLEDQAFKECPQ--------------------LELLDVAFTHL------HVKAPHSPFQNLHLLRVLNLSHCLLDTSNQHLLAGLQDLRHLNLQGNS................................................................................................................................................................... 459
64 -30.5003cig_A mol:protein length:697 Toll-like receptor 3  ali model follow..  11  3.TVRYNVADCSHLKLTHIPDDL--PSNITVLNLTHNPTNFTRYSQLAILDAGFNSIPELCQILPLLKVLNLNELSQIDQTFVFCTNLTELDLMSNSIHKISNPFKNQKNLIKLDLSHNGLSSTLGTGVQLENLQELLLAKNKILALRSEELEFNSSLRKLDLSSNPLKEFPGCFQTIGKLFALLLNNANPHLTEKLCWELSNTSIQNLSLANNQLLATSESTFSGLKWTNLLDLSYNNLHDVGNGSFSYLPSLRYLSLEYNNIQRLPRSFYGLSNLRYLSLKRAFTKQSDFSFQWLKYLEYLNMDDNNIPSTSNTFTGLVSLKYLSLSKTFT-----SLQTLTNETFVSLAHSPLLTLNLTKNHISKIANGTFSWLGQ--------------------LRILDLGLNEI------EQKLSGQEWRGLRNIFEIYLSYNKYLQLSTSSFALVPSLQRLMLRRVA................................................................................................................................................................... 465
65 -30.4004z63_A mol:protein length:631 Phytosulfokine receptor 1  ali model follow..  9  172.CVLLEHLCLGMNDLTNIPEDLFHLKRLNLLGIQENSREIRNLSSLVRLDVSWNEIPDVFDELPQLKFFLGQTNGGIPKSLANSPSLNLLNLRNNSLSRLMLNCTAMIALNSLDLGTNRFNRLPENLPDCKRLKNVNLARNTFHQVPESFKNF-ESLSYFSLSNSSLANISSILQHCKNLTTLVLTLNFHGEALPDDSSLHFEKLKVLVVANCRLTGSMPRWLSSSNELQLLDLSWNRLTGAIPSWIGDFKALFYLDLSNNSFTEIPKSLTKLESLTSRNISVNEPSDFPFFMKRNESAPTIELGHNNLSPIWEEFGNLKKLHVFDLKWNALS----------SIPSSLSGMTSLEALDLSNNRLSGSIPVSLQQLSFLSKAYNNLSGVIPSGGQFQTFPNSSFESNHLCGEHRFPCSEGT............................................................................................................................................................................................................. 619
66 -30.2004psj_A mol:protein length:271 OR464  ali model follow..  17  41.LNSIDQINANNSDIKSVQ-GIQYLPNVRQLNLGGNISALKELTNLGWLNLSSNKIEKLFESLTTLTQLNLNQITSLPQGFESLASLTQLNLSNNQITSLPQGFESLTNLTQLNLSNNQITSLPQGFESLTNLTQLNLSNNQITSLPQGLFESLTSLTQLNLSNNQITSLPQGFESLTNLKQLNLSGN...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 240
67 -30.2005yq5_A mol:protein length:430 Osteomodulin  ali model follow..  10  87IPMHIQQLYLQFNEIEAVTANFINATHLKEINLSHNYGVFAKLPNLLQLHLEHNNLEFPFPLPKSLERLLLNEISKLQTNMDGLVNLTMLDLCYNYLHDSDKIFAKMEKLMQLNLCSNRLESMPPGL--PSSLMYLSLENNSISSIPEKYFDKLPKLHTLRMSHNKLQDIPYNIFNLPNIVELSVGHNKL--KQAFYIPRNLEHLYLQNNEIEKMNLTVIDPLHYHHLTYIRVDQNKLKEPISSYIFFCFPHIHTIYYGEQRSTNGQ-----------------TIQLKTQVFRRFPDDDDESEDHDDPDNAHESPEQEGAEGHFDLHYYENQEAAADY............................................................................................................................................................................................................................................................................................... 424
68 -30.2003cvr_A mol:protein length:571 Invasion plasmid antigen  ali model follow..  12  10.NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNINQFSELQLNRLNLSSLPDNLPPQITVLEITQNALISLPELPASLEYLDACDNRLSTLPELPA------SLKHLDVDNNQLTMLPELP---ALLEYINADNNQLTMLPELP----TSLEVLSVRNNQLTFLPELPESLEALDV--STNLLESLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQS---NNLRKTLLVHQASEGLFDNDTGALLSLGREMFRLEILEDIARDKVTLHFVDEIEVYLAFQTMLAEKLQLSTAVKEMRFYGVSVTANDLRTAEAMVRSREENE............................................................................................................................................................................ 475
69 -30.1001g9u_A mol:protein length:454 OUTER PROTEIN YOPM  ali model follow..  12  12...FLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWS-CLDRQAHELELNNLGLSSLPELPPHLESLV-ASCNSLTELPELPQSLKSLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKKLPDL---PPSLEFIAAGNNQLEELPE-LQNL-PFLTAIYADNNSLKKLPDLPLSLESIVAGNNILE------ELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTD-----LPELPQSLTFLDVSENIFSGLSELP------PNLYYLNASSNEIRSLCDLPPSL---EELNVSNNKLIELPALPP---RLERLIASFNHLAEVPELPQNLKQL-------------HVEYNPLREFPDIPESV-----EDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVED............................................................................................................................................................................................................. 420
70 -30.1004lxr_A mol:protein length:783 Protein toll  ali model follow..  9  98.VSPTTLIFESDNLGMNITRQLDRLHGLKRFRFTTRLTDMRNLSHLELRANIEEMPSHLFDDLENLESIEFNKLRQMPRGFGKMPKLKQLNLWSNQLHNLTKDFEGATSVLGIDIHDNGIEQLPHDFAHLTNVTDINLSANLFRSLPQGLFDHNKHLNEVRLMNNRVPTLPSRFANQPELQILRLRAELQSLPGDL--FEHSTQITNISLGDNLLKTLPATLLEHQVNLLSLDLSNNRLTHLPDSLFAHTTNLTDLRLEDNLLTGISGDISNLGNLVTLVMSRNRLRTIDSAFVSTNGLRHLHLDHNDIDLQQPPFGYMHGLLTLNLRNNSIIFVYNDW---------KNTMLQLRELDLSYNNISSLGYEDLAFLSQNRLHVNMTHNK............................................................................................................................................................................................................................................. 506
71 -30.0002o6q_A mol:protein length:270 Variable lymphocyte receptor A  ali model follow..  16  15.NNNKNSVDCSSKKLTAIPSNI--PADTKKLDLQSNSKAFHRLTKLRLLYLNDNKLQTIFKELKNLETLWVNKLQALPIGFDQLVNLAELRLDRNQLKSLPPVFDSLTKLTYLSLGYNELQSLPKVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGFDSLEKLKMLQLQEN...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 215
72 -30.0005ijb_A mol:protein length:594 Toll-like receptor 4, Variable lymphocyte receptor B chimera  ali model follow..  12  6.VVPNITYQCMDQKLSKVPDDI--PSSTKNIDLSFNSYSFSNFSELQWLDLSRCEIDKAWHGLHHLSNLILNPIQSFPGSFSGLTSLENLVAVETKLASLESPIGQLITLKKLNVAHNFIHSCPAYFSNLTNLVHVDLSYNYIQTITVNLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDPTLDLPFLKSLTLTMNKGSISF-KKVALPSLSYLDLSRNALSFSGCCS-GTNSLRHLDLSFNGAIIMSANFMGLEELQSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE-------QISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLKELALDTNQLK................................................................................................................................................................. 530
73 -30.0003j0a_A mol:protein length:844 Toll-like receptor 5  ali model follow..  8  3.SFDGRIAFYRFCNLTQVPQ---VLNTTERLLLSFN-SSFPFLEQLQLLELGSQYTPLTIDNLPNLRILDLSKIYFLHPDFQGLFHLFELRLYFCGLSDADGYFRNLKALTRLDLSKNQIRSLYLHFGKLNSLKSIDFSSNQIFLVCEHELE-GKTLSFFSLAANSLYSRVSVD---HIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNYGLPKVAYIDLQKNHIAIIQDQTKFLEKLQTLDLRDNALTT----IHFIPSIPDIFLSGNKLVTLPKINLTANLIHYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMWDVFEGLSHLQVLYLNHNYLN-------SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIY................................................................................................................... 587
74 -29.9003kj4_A mol:protein length:286 Reticulon-4 receptor  ali model follow..  13  29IPASSQRIFLHGNRISYVPAAFQSCRNLTILWLHSNAAAFTGLTLLEQLDLSDNAQPTTFRGLGHLHTLHLCGLQELGPGFRGLAALQYLYLQDNNLQALPDTFRDLGNLTHLFLHGNRIPSVPEAFRGLHSLDRLLLHQNHVARVHPHAFRDLGRLMTLYLFANNLSMLPAELVPLRSLQYLRLNDN...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 234
75 -29.9003e6j_A mol:protein length:229 Variable lymphocyte receptor diversity region  ali model follow..  15  16.....TTVDCRSKRHASVPAGI---TNAQILYLHDN--QITKLE------------PGVFDSLINLKELYLNQLGALPVGFDSLTQLTVLDLGTNQLTVLPSVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRDIMYLRNWVA............................................................................................................................................................................................................................................................................................................................................................................................................................................................ 180
FFAS is supported by the NIH grant R01-GM087218-01
1 4 8 3 2 2   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster
Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Reed JC, Doctor K, Rojas A, Zapata JM, Stehlik C, Fiorentino L, Damiano J, Roth W, Matsuzawa S, Newman R, Takayama S, Marusawa H, Xu F, Salvesen G, Godzik A.; RIKEN GER Group; GSL Members. Comparative analysis of apoptosis and inflammation genes of mice and humans. Genome Res. 2003 Jun;13(6B):1376-88.